SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-290270
Filing Date
2023-12-07
Accepted
2023-12-07 06:11:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d589962d424b5.htm 424B5 454372
2 GRAPHIC g589962g36a36.jpg GRAPHIC 68909
3 GRAPHIC g589962g39x41.jpg GRAPHIC 67477
  Complete submission text file 0001193125-23-290270.txt   643735
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-275125 | Film No.: 231471021
SIC: 3826 Laboratory Analytical Instruments